
Effective Deprescribing: Individualizing Chronic Disease Management and Enhancing Patient Safety
Activity Description
This course will define the importance of and strategies for deprescribing. The relationship between polypharmacy and deprescribing will be defined. The role of the healthcare and/or case management team pertaining to deprescribing efforts and the importance of multidisciplinary collaboration will also be examined.
Target Audience
Learning Objectives
Define the relationship between polypharmacy and deprescribing
Discuss the importance of deprescribing
Evaluate strategies for deprescribing within two drug categories
Examine the role of the healthcare team pertaining to deprescribing efforts and multidisciplinary collaboration
Additional Information
| Attachment | Size |
|---|---|
| 381.31 KB |
| Name | Role | Disclosure of Relevant Financial Relationships with Ineligible Company |
|---|---|---|
Kari Muskopf Occupational Therapist | Other licensed training | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Alison Sutton Pharmacist | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Lawanna Gaddy Nurse | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Katherine Quinlan Pharmacy Technician | Other non-licensed training | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Lauren Takeda Pharmacist | Planner & Speaker | No relevant financial relationship(s) with ineligible companies to disclose |
Mallory Thompson Pharmacist | Planner & Speaker | No relevant financial relationship(s) with ineligible companies to disclose |
Chris Hoover Nurse | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Alice Krull Physician | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Jena Klosteridis Pharmacist | Independent Reviewer | No relevant financial relationship(s) with ineligible companies to disclose |
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Centene Institute for Advanced Health Education (Centene Institute) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. Centene Institute ensures that the content is independent of commercial bias.
None of the Centene Institute staff members have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


Universal Activity Number UAN JA4008309-0000-24-005-H05-P/T
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board-certified case managers. The course is approved for 1.00 CE contact hour(s).Activity code: I00065725 Approval Number: 250004021
To claim these CEs, log into your CCMC Dashboard at www.ccmcertification.org.
This certificate must be retained for one year past the participant's CCM board-certified case manager's renewal date.

Available Credit
- 1.00 ACPE Pharmacy
- 1.00 ACPE Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Attendance/Participation
- 1.00 CCMC Case Manager
- 1.00 IPCE
Since CE boards may have changes in requirements, it is the responsibility of the attendee to verify with their boards if they accept the CEs being offered.
Required Hardware/software
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software.

Facebook
X
LinkedIn
Forward